Silverback Therapeutics, Inc.

Araris Biotech Ag

Robert Dubose

Peter Robert Baum

Valerie Odegard

Brenda L Stevens

Philip Tan

Sean Wesley Smith

Brenda Stevens

Peter A Thompson

The present disclosure provides conjugates of anti-Nectin-4 antibodies or antigen binding fragments thereof to a myeloid cell agonist, compositions comprising the conjugates, and methods of treating cancer with the conjugates. The present disclosure also provides for anti-Nectin-4 antibodies or antigen binding fragments thereof and method for using the antibodies or antigen binding fragments thereof in treating cancer.

Nectin-4 antibody conjugates and uses thereof

The disclosure provides conjugates of anti-ASGR1 antibodies or antigen binding fragments thereof to a myeloid cell agonist, compositions comprising the conjugates, and methods of treating liver viral infections with the conjugates. The disclosure also provides for anti-ASGR1 antibodies or antigen binding fragments thereof and methods for using the antibodies or antigen binding fragments thereof in treating liver viral infections.

Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof

Growing community of inventors

Seattle, WA, United States of America

Robert Dubose